The Latest Cardiac and Vascular News
Analysis is first to compare health system-based electronic health record data for treatment of pulmonary embolism with interventional devices MARLBOROUGH, Mass., Oct. 24, 2023 /PRNewswire/ — Data from the REAL-PE study was presented today at Transcatheter Cardiovascular Therapeutics…
KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc., the AI-Powered Cardiac Blood Test Company, today announces the presentation of patient data demonstrating that its Artificial Intelligence (AI)-driven HART® CVE blood test is highly accurate for risk assessment in patients with total blockage of a heart artery, also known as coronary Chronic Total Occlusion (CTO). Researchers from Massachusetts General Hospital (MGH) tested 241 patients with chronic total occlusion of at least one coronary (hea
CoSo Health to exclusively distribute Medinol’s most advanced coronary DES in the U.S. DENVER and TEL AVIV, Israel, Oct. 24, 2023 /PRNewswire/ — Medinol today announced United States Food and Drug Administration (FDA) approval for the EluNIR-PERL™ drug-eluting stent (DES) for the…
Research affirms Implicity’s algorithm* is highly effective at identifying patterns and classifying AF episodes into medically relevant events that require clinical action CAMBRIDGE, Mass., Oct. 24, 2023 /PRNewswire/ — Implicity, a leader in remote patient monitoring (RPM) and cardiac…
IRVINE, Calif.–(BUSINESS WIRE)– #DETOURSystem–Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, proudly announces recent awards and nominations for its groundbreaking DETOUR System. Percutaneous Transmural Arterial Bypass (PTAB) with the DETOUR System offers a novel approach to treating complex PAD, enabling physicians to bypass lesions in the superficial femoral artery, by using conduits routed th
MIAMI LAKES, Fla., Oct. 24, 2023 /PRNewswire/ — Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technology, has announced completion of patient enrollment in SUCCESS PTA, its large post-market study with the SELUTION SLR™…
HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE, “the Company”), a company primarily focused on leveraging its novel and proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, today announced the appointment of Niv Ad, M.D. as Chief Science Officer, Cardiac Surgery. “After working with the Pulse Biosciences’ team and participating in preclinical studies using the nsPFA clamp for cardiac ablation, it was immediately clear
SAN MATEO, Calif. & HOUSTON, Mo.–(BUSINESS WIRE)–RapidAI, a global leader in developing Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, cardiac and vascular diseases, is pleased to announce Texas County Memorial Hospital’s (TCMH) implementation of RapidAI’s core stroke imaging and workflow products – including Rapid ICH, LVO, CTA and CTP – as part of its ongoing commitment to enhancing the quality of stroke care for patients in rural so
NEUCHATEL, Switzerland, Oct. 24, 2023 /PRNewswire/ — Aktiia SA, the world leader in cuffless blood pressure technology, is proud to announce its collaboration with the Genetic and phenotypic determinants of blood pressure and other cardiovascular risk factors (GAPP) study investigators,…
SAN FRANCISCO, Oct. 24, 2023 /PRNewswire/ — Frontier Bio Corporation has unveiled a transformative method designed to fabricate living human blood vessels, setting the stage for a radical shift in medical device testing. At present, vascular medical devices must be assessed for safety…
